The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association of tumor infiltrating lymphocytes (TILs) with molecular subtype and prognosis in stage III colon cancers (CC) from a FOLFOX-based adjuvant chemotherapy trial.
 
Frank A. Sinicrope
Stock and Other Ownership Interests - Gilead Sciences; illumina
Consulting or Advisory Role - Ventana Medical Systems
Travel, Accommodations, Expenses - ventana medical systems
 
Thomas C. Smyrk
No Relationships to Disclose
 
Nathan R. Foster
No Relationships to Disclose
 
Jeffrey P. Meyers
No Relationships to Disclose
 
Stephen N. Thibodeau
No Relationships to Disclose
 
Richard M. Goldberg
Honoraria - Baxter; Biothera; Forty Seven; Immunocare Therapies; Immunovative Therapies; kanghong Pharma; Lilly; Merck; Momenta Pharmaceuticals; Novo Nordisk; Pfizer; Sirtex Medical; Taiho Pharmaceutical; Targovax
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Immunomedics (Inst); Merck (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Amgen; Baxter; Merck KGaA; Sanofi
 
Qian Shi
No Relationships to Disclose
 
Daniel J. Sargent
Consulting or Advisory Role - Abbvie; Acerta Pharma; ARIAD; Astellas Pharma; AstraZeneca/MedImmune; Biothera; Celldex; Exelixis; Genentech; Incyte; Kyowa Hakko Kirin; Medivation; Merck; Merrimack; Nektar; Novartis; Pharmacyclics; Pique; Spiration; Xbiotech
Research Funding - Celgene (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Celgene
 
Steven R. Alberts
No Relationships to Disclose